Dimensional Fund Advisors
SIOX

Dimensional Fund Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Dimensional Fund Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,749
Closed -$7K – 3547
2022
Q2 		$7K Sell
20,749
-169,921
-89% -$70.3K ﹤0.01% 3460
2022
Q1 		$128K Sell
190,670
-362,064
-66% -$307K ﹤0.01% 3369
2021
Q4 		$713K Buy
552,734
+161,102
+41% +$286K ﹤0.01% 3099
2021
Q3 		$850K Buy
391,632
+293,348
+298% +$638K ﹤0.01% 3079
2021
Q2 		$268K Buy
98,284
+13,389
+16% +$33.3K ﹤0.01% 3282
2021
Q1 		$222K Buy
84,895
+51,267
+152% +$145K ﹤0.01% 3275
2020
Q4 		$93K Buy
33,628
+15,628
+87% +$45.5K ﹤0.01% 3281
2020
Q3 		$83K Buy
+18,000
New +$59.4K ﹤0.01% 3279
2020
Q1 		– Sell
-10,826
Closed -$55K – 3398
2019
Q4 		$55K Sell
10,826
-2,285
-17% -$12.7K ﹤0.01% 3345
2019
Q3 		$85K Buy
+13,111
New +$90.4K ﹤0.01% 3352

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Dimensional Fund Advisors's SIOX Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2022, closing a stake of 20,749 shares — an estimated $7K sold.

Dimensional Fund Advisors first reported a position in SIOX in Q3 2019 and held it in 10 quarters. The position peaked at $850K in Q3 2021. 40 funds tracked by Wall St. Rank hold SIOX as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 20,749 Sio Gene Therapies Inc. Common Stock shares in Q3 2022, an estimated $7K.
  • Dimensional Fund Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • Dimensional Fund Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $850K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.